Arcus Biosciences Inc (NYSE: RCUS) is 0.20% higher on its value in year-to-date trading and has touched a low of $13.52 and a high of $20.31 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The RCUS stock was last observed hovering at around $15.24 in the last trading session, with the day’s loss setting it -0.32%.
Currently trading at $14.92, the stock is -5.37% and -6.04% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.39 million and changing -2.10% at the moment leaves the stock -7.23% off its SMA200. RCUS registered -20.55% loss for a year compared to 6-month gain of 7.03%. The firm has a 50-day simple moving average (SMA 50) of $15.9078 and a 200-day simple moving average (SMA200) of $16.09025.
The stock witnessed a -13.71% loss in the last 1 month and extending the period to 3 months gives it a -14.60%, and is 0.20% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.16% over the week and 4.80% over the month.
Arcus Biosciences Inc (RCUS) has around 577 employees, a market worth around $1.37B and $263.00M in sales. Profit margin for the company is -102.66%. Distance from 52-week low is 10.36% and -26.54% from its 52-week high. The company has generated returns on investments over the last 12 months (-44.12%).
The EPS is expected to grow by 17.81% this year
267.0 institutions hold shares in Arcus Biosciences Inc (RCUS), with institutional investors hold 97.64% of the company’s shares. The shares outstanding are 91.50M, and float is at 49.26M with Short Float at 15.00%. Institutions hold 59.67% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 9.76 million shares valued at $148.69 million. The investor’s holdings represent 11.3261 of the RCUS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 5.26 million shares valued at $80.07 million to account for 6.099 of the shares outstanding. The other top investors are WOODLINE PARTNERS LP which holds 4.25 million shares representing 4.9249 and valued at over $64.65 million, while FMR LLC holds 4.8501 of the shares totaling 4.18 million with a market value of $63.67 million.
Arcus Biosciences Inc (RCUS) Insider Activity
The most recent transaction is an insider sale by Goeltz II Robert C., the company’s Chief Financial Officer. SEC filings show that Goeltz II Robert C. sold 3,594 shares of the company’s common stock on Dec 31 ’24 at a price of $15.00 per share for a total of $53910.0. Following the sale, the insider now owns 60138.0 shares.
Still, SEC filings show that on Dec 02 ’24, Azoy Alexander (Chief Accounting Officer) disposed off 201 shares at an average price of $15.32 for $3079.0. The insider now directly holds 19,070 shares of Arcus Biosciences Inc (RCUS).
